Philip Keiser

5.0k total citations · 2 hit papers
81 papers, 3.8k citations indexed

About

Philip Keiser is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Philip Keiser has authored 81 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 22 papers in Virology and 18 papers in Epidemiology. Recurrent topics in Philip Keiser's work include HIV/AIDS Research and Interventions (24 papers), HIV Research and Treatment (21 papers) and HIV/AIDS drug development and treatment (20 papers). Philip Keiser is often cited by papers focused on HIV/AIDS Research and Interventions (24 papers), HIV Research and Treatment (21 papers) and HIV/AIDS drug development and treatment (20 papers). Philip Keiser collaborates with scholars based in United States, Kenya and France. Philip Keiser's co-authors include Daniel C. Douek, Richard A. Koup, Louis J. Picker, Earl A. Gage, Barton F. Haynes, Janice M. Massey, Michael A. Polis, Jerome A. Zack, Beth D. Jamieson and Ashley T. Haase and has published in prestigious journals such as Nature, The Journal of Immunology and PLoS ONE.

In The Last Decade

Philip Keiser

79 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Changes in thymic function with age and during the treatment of HIV infection

1998 1.5k citations Daniel C. Douek, Philip Keiser et al. profile →
Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients

2010 414 citations Ryan Cooper, Natasha Wiebe et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Keiser United States	21	1.8k	1.3k	1.2k	1.1k	623	81	3.8k
Arye Rubinstein United States	34	1.5k 0.9×	1.3k 1.0×	1.1k 0.9×	1.4k 1.3×	402 0.6×	115	3.7k
Jan C.C. Borleffs Netherlands	27	1.6k 0.9×	1.4k 1.1×	779 0.7×	1.0k 1.0×	394 0.6×	97	3.4k
Ian Williams United Kingdom	33	1.5k 0.9×	1.5k 1.2×	781 0.7×	808 0.8×	756 1.2×	102	3.2k
Paul R. Skolnik United States	35	1.9k 1.1×	1.8k 1.4×	997 0.8×	1.5k 1.4×	586 0.9×	77	4.2k
Terese L. Katzenstein Denmark	29	1.6k 0.9×	1.3k 1.0×	597 0.5×	964 0.9×	439 0.7×	195	3.3k
Carsten Schade Larsen Denmark	33	2.0k 1.2×	1.1k 0.9×	634 0.5×	1.2k 1.1×	1.4k 2.3×	176	4.0k
Hans Spiegel United States	27	1.3k 0.7×	1.2k 0.9×	1.2k 1.0×	912 0.9×	231 0.4×	71	3.0k
Denise L. Jacobson United States	38	2.3k 1.3×	811 0.6×	635 0.5×	1.1k 1.0×	1.9k 3.0×	96	5.2k
Marijke Roos Netherlands	37	2.3k 1.3×	3.3k 2.6×	2.2k 1.8×	1.4k 1.3×	520 0.8×	56	5.4k
Jacquie Astemborski United States	44	2.0k 1.1×	1.2k 1.0×	1.5k 1.2×	4.6k 4.3×	581 0.9×	115	7.2k

Countries citing papers authored by Philip Keiser

Since Specialization

Citations

This map shows the geographic impact of Philip Keiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Keiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Keiser more than expected).

Fields of papers citing papers by Philip Keiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Keiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Keiser. The network helps show where Philip Keiser may publish in the future.

Co-authorship network of co-authors of Philip Keiser

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Keiser. A scholar is included among the top collaborators of Philip Keiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Keiser. Philip Keiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goodman, Michael L., Andrew E. Springer, Christine Markham, et al.. (2023). Enabling structural resilience of street-involved children and youth in Kenya: reintegration outcomes and the Flourishing Community model. Frontiers in Psychology. 14. 1175593–1175593. 8 indexed citations

Davis, John W., et al.. (2022). Prediction of the need for intensive oxygen supplementation during hospitalisation among subjects with COVID-19 admitted to an academic health system in Texas: a retrospective cohort study and multivariable regression model. BMJ Open. 12(3). e058238–e058238. 1 indexed citations

Bente, Dennis A., Scott C. Weaver, Gary Kobinger, et al.. (2022). Texas professionals are employing a one health approach to protect the United States against biosecurity threats. One Health. 15. 100431–100431.

Goodman, Michael L., et al.. (2020). Intimate Partnerships, Suicidal Ideation and Suicide-Related Hospitalization Among Young Kenyan Men. Community Mental Health Journal. 56(7). 1225–1238. 5 indexed citations

Pal, Rahul, Sandra M. Cardona, Victor H. Carpio, et al.. (2018). Elimination of intravascular thrombi prevents early mortality and reduces gliosis in hyper-inflammatory experimental cerebral malaria. Journal of Neuroinflammation. 15(1). 173–173. 15 indexed citations

Goodman, Michael L., et al.. (2017). How do Kenyan orphan girls experience less meaningful lives and how much does it matter for ‘health’?. Quality of Life Research. 26(6). 1551–1559. 7 indexed citations

Goodman, Michael L., et al.. (2016). Testing and testing positive: childhood adversities and later life HIV status among Kenyan women and their partners. Journal of Public Health. 39(4). 720–729. 6 indexed citations

Huante, Matthew B., et al.. (2013). Mycobacterium tuberculosis-specific CD8+T cell recall in convalescing TB subjects with HIV co-infection. Tuberculosis. 93. S60–S65. 8 indexed citations

Cooper, Ryan, Natasha Wiebe, Nathaniel Smith, et al.. (2010). Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients. Clinical Infectious Diseases. 51(5). 496–505. 414 indexed citations breakdown →

10.

Keiser, Philip, et al.. (2007). Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection. Expert Opinion on Pharmacotherapy. 8(4). 477–483. 4 indexed citations

11.

Keiser, Philip, Michael Sension, Edwin DeJesus, et al.. (2005). Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment. BMC Infectious Diseases. 5(1). 2–2. 31 indexed citations

12.

Gebo, Kelly A., John A. Fleishman, Richard Conviser, et al.. (2004). Racial and Gender Disparities in Receipt of Highly Active Antiretroviral Therapy Persist in a Multistate Sample of HIV Patients in 2001. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(1). 96–103. 240 indexed citations

13.

Saavedra‐Lozano, Jesús, Cynthia McCoig, Jinbo Xu, et al.. (2002). An Anti‐CD45RO Immunotoxin Kills Latently Infected Human Immunodeficiency Virus (HIV) CD4 T Cells in the Blood of HIV‐Positive Persons. The Journal of Infectious Diseases. 185(3). 306–314. 12 indexed citations

14.

Haubrich, Richard, Carol A. Kemper, Nicholas S. Hellmann, et al.. (2002). The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility. AIDS. 16(15). F33–F40. 58 indexed citations

15.

Douek, Daniel C., Michael R. Betts, Brenna J. Hill, et al.. (2001). Evidence for Increased T Cell Turnover and Decreased Thymic Output in HIV Infection. The Journal of Immunology. 167(11). 6663–6668. 192 indexed citations

16.

Kaplan, Norman M., et al.. (1998). Keeping Travelers Healthy. The American Journal of the Medical Sciences. 315(5). 327–336. 1 indexed citations

17.

Skiest, Daniel J. & Philip Keiser. (1997). Clinical significance of eosinophilia in HIV-infected individuals. The American Journal of Medicine. 102(5). 449–453. 50 indexed citations

18.

Keiser, Philip, Steven Rademacher, & James W. Smith. (1997). Utility of bone marrow culture and biopsy in the diagnosis of disseminated infections in AIDS. American Journal of Hematology. 56(1). 1–4. 11 indexed citations

19.

Chaisson, Richard E., Philip Keiser, Mark A. Pierce, et al.. (1997). Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic. AIDS. 11(3). 311–317. 105 indexed citations

20.

Keiser, Philip, et al.. (1992). Anti-CD4 Antibodies are Associated with HIV-1 Seroconversion and May Be Detectable Before Anti-HIV-1 Antibodies. AIDS Research and Human Retroviruses. 8(11). 1919–1927. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact